Stereochemical Studies of Hexylitaconic Acid, an Inhibitor of P53–HDM2 Interaction

Bioorganic and Medicinal Chemistry Letters - United Kingdom
doi 10.1016/j.bmcl.2009.04.057
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P53 Mediated Death of Cells Overexpressing MDM2 by an Inhibitor of MDM2 Interaction With P53

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Inhibition of Wild-Type P53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Specific Domains of Nucleolin Interact With Hdm2 and Antagonize Hdm2-Mediated P53 Ubiquitination

FEBS Journal
BiochemistryCell BiologyMolecular Biology
2011English

A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced P53 Degradation by HDM2 in Response to DNA Damage

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Discovery of SCY45, a Natural Small‐Molecule MDM2‐p53 Interaction Inhibitor.

Chemistry and Biodiversity
Molecular MedicineMolecular BiologyBiochemistryMedicineBioengineeringChemistry
2019English

Nucleolin Inhibits Hdm2 by Multiple Pathways Leading to P53 Stabilization

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

DDX31 Regulates the P53-Hdm2 Pathway and rRNA Gene Transcription Through Its Interaction With NPM1 in Renal Cell Carcinomas

Cancer Research
Cancer ResearchOncology
2012English

The Warfarin-Cimetidine Interaction: Stereochemical Considerations.

British Journal of Clinical Pharmacology
Pharmacology
1986English

Hdm2 Recruits a Hypoxia-Sensitive Corepressor to Negatively Regulate P53-Dependent Transcription

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy